Study guide
Federal Regulatory Framework & Advisory Authorities
ABMP Medical Health Physics Exam
Track your progress as you read
Finished sections get a check mark.
1 Radiation Detection Instrumentation
Ionization Chambers & Geiger-Mueller Counters Scintillation Detectors, Photomultipliers & Gamma Spectroscopy Liquid Scintillation & Gamma Counting Systems: Well Counters & Thyroid Probes Personnel Dosimeters & Electronic Radiation Monitors Neutron Detection & Emergency Field Instrumentation
2 Laboratory Design & Contamination Control
Radiopharmaceutical Laboratory Design & USP <825> Standards Ventilation Systems, Fume Hoods & Contamination Engineering
3 Radiation Protection Standards & Dose Limits
Federal Regulatory Framework & Advisory Authorities Federal Guidance Documents: NRC Regulatory Guides, NUREGs, EPA & FDA Guidance Occupational & Public Dose Limits and ALARA Principles Radiobiological Basis of Limits & Risk Communication
4 Medical Licensing, Written Directives & Security
NRC Form 313 Authorizations, RSO Responsibilities & Written Directives Medical Event Reporting & 10 CFR 37 Category 1/2 Source Security
5 Diagnostic Radiology Structural Shielding
Diagnostic Shielding Methodology: NCRP Report 147 Modality Shielding: Radiography, Fluoroscopy & CT Facilities
6 Megavoltage Therapy Vault & Facility Shielding
Megavoltage Vault Primary & Secondary Barriers: NCRP Report 151 Therapy Maze Design, Photoneutrons & Shielded Doors PET/CT & Nuclear Medicine Facility Shielding (AAPM TG-108)
7 Radiation Oncology Quality Management & Safety
External Beam QA & Dosimetry Calibration Protocols Brachytherapy Safety, Inventory Control & Leak Testing
8 Radiation Oncology Emergency Procedures & TPS QA
Treatment Planning System (TPS) QA & Patient Verification Radiation Oncology Emergency Procedures: HDR Stuck Sources & Linac Failures Medical Events, Incident Investigation & Joint Commission Requirements in Radiation Oncology
9 Diagnostic Imaging Safety & Fluoroscopy Management
Diagnostic X-ray & Fluoroscopy Safety Interventional Fluoroscopy Dose Management & NCRP Report 168
10 CT Optimization, MQSA & Diagnostic Accreditation
Computed Tomography Dosimetry & Protocol Optimization Mammography Quality Standards Act (MQSA) & Mammography Physics Diagnostic Imaging Quality Management, Accreditation & Regulatory Oversight
11 Nuclear Medicine Radiopharmacy & Unsealed Therapy
Radiopharmaceutical QC & Radionuclide Calibrators Unsealed Source Therapy: I-131 Protocols & Patient Release Criteria
12 Targeted Radionuclide Therapy, Decontamination & RAM Transport
Targeted Radionuclide Therapies: Lu-177, Ra-223, Y-90 & Radioimmunotherapy Contamination Surveys, Spill Response & Personnel Decontamination Radioactive Waste Disposal & US DOT Transport Regulations
13 Radiobiology & Radiation Risk Assessment
Cellular Radiobiology, DNA Damage & Dose-Response Models Prenatal Radiation Risks & Population Exposures
14 Non-Ionizing Radiation Safety: Lasers & MRI
Healthcare Laser Safety: ANSI Z136.1 & Z136.3 MRI Safety, Facility Design & Bioeffects
Federal Regulatory Framework & Advisory Authorities
Key Takeaways Explain This Topic AI
The US Nuclear Regulatory Commission (NRC) derives its statutory authority from the Atomic Energy Act of 1954 and Energy Reorganization Act of 1974, regulating byproduct material under Title 10 of the Code of Federal Regulations.
Under Section 274b of the Atomic Energy Act, Agreement States assume regulatory authority over byproduct materials while maintaining compatibility categories A, B, C, D, and Health & Safety.
The Energy Policy Act of 2005 expanded NRC byproduct jurisdiction to include accelerator-produced radioactive materials and discrete sources of radium-226, unifying oversight of medical cyclotron products.
Radioactive materials transport is governed by 49 CFR Parts 171–178 under a DOT-NRC Memorandum of Understanding, categorizing shipments into Excepted, Type A, and Type B packages based on activity limits A 1 A_1 A 1 and A 2 A_2 A 2 .
Last updated: October 2026
Statutory Authority & Title 10 Code of Federal Regulations
The regulation of ionizing radiation in the United States derives from the Atomic Energy Act (AEA) of 1954, as amended. The Energy Reorganization Act of 1974 abolished the Atomic Energy Commission, creating the US Nuclear Regulatory Commission (NRC) as an independent regulatory agency with statutory jurisdiction over source, special nuclear, and byproduct materials under Title 10 of the Code of Federal Regulations (10 CFR).
Within healthcare facilities, the NRC enforces three core regulatory parts:
10 CFR Part 19: Governs notices, instructions, and reports to radiation workers, employee inspection rights, mandatory posting of NRC Form 3 ("Notice to Employees"), and workers' rights to receive annual exposure reports.
10 CFR Part 20: Codifies radiation protection standards, binding occupational and public dose limits, dosimetric summation rules, surveys, radioactive waste management, and the legal requirement to maintain exposures As Low As Reasonably Achievable (ALARA).
10 CFR Part 35: Regulates the medical use of byproduct material for diagnostic and therapeutic administrations. Part 35 establishes qualifications for Radiation Safety Officers (RSOs), Authorized Users (AUs), and Authorized Medical Physicists (AMPs); mandates written directives (10 CFR 35.40); regulates dosage calibration and sealed source leak testing; and establishes medical event reporting thresholds (10 CFR 35.3045).
The Energy Policy Act of 2005
Historically, the AEA limited byproduct material to materials produced in nuclear reactors. Accelerator-produced radioactive material (ARM)—including cyclotron PET radionuclides ( 18 F ^{18}\text{F} 18 F , 11 C ^{11}\text{C} 11 C , 13 N ^{13}\text{N} 13 N , 15 O ^{15}\text{O} 15 O , 201 Tl ^{201}\text{Tl} 201 Tl , 67 Ga ^{67}\text{Ga} 67 Ga , 111 In ^{111}\text{In} 111 In ) and discrete sources of radium-226 and naturally occurring radioactive material (NORM)—were categorized as NARM and regulated exclusively by individual states.
The Energy Policy Act of 2005 (EPAct 2005) permanently expanded the AEA Section 11e definition of byproduct material to include cyclotron-produced radionuclides, discrete sources of Ra-226, and accelerator materials used in commercial, medical, or research activities. Consequently, all accelerator-produced radiopharmaceuticals and discrete NORM sources are now federally regulated under 10 CFR Parts 20, 30, 32, and 35 or corresponding Agreement State codes.
The Agreement State Program & Compatibility Framework
Under Section 274b of the Atomic Energy Act, the NRC enters into formal agreements relinquishing regulatory authority over byproduct, source, and small quantities of special nuclear materials to state governments. These Agreement States (41 states since Indiana's agreement took effect on September 30, 2026) regulate the majority of US medical radiation programs.
Under NRC Management Directive 5.9, each NRC rule is assigned a compatibility category (in addition to an "NRC" category for areas the Commission reserves to itself, such as reactor regulation):
Category A: Basic radiation protection standards, fundamental definitions, and dose limits (e.g., TEDE limits, tissue weighting factors). State regulations must be essentially identical to federal rules.
Category B: Cross-jurisdictional program elements (e.g., radioactive materials transportation, reciprocity). State rules must be essentially identical.
Category C: Essential program objectives where the state must adopt the core intent, but retains flexibility to implement more stringent or restrictive requirements.
Category D: Regulations not required for compatibility.
Category H&S: Elements possessing direct health and safety significance that states must adopt, though procedural flexibility is permitted.
The NRC retains non-delegable jurisdiction over nuclear power plants, federal facilities, and international import/export. Crucially, radiation-producing machines (diagnostic x-ray units, CT scanners, linear accelerators) do not involve byproduct material; their registration, clinical operation, and room shielding plans are regulated by state radiation control agencies or OSHA, not the NRC.
Transportation of Radioactive Materials: DOT 49 CFR & Package Classification
Transportation of radioactive materials in commerce is governed by the US Department of Transportation (DOT) under Title 49 CFR Parts 171–178 through a formal Memorandum of Understanding (MOU) with the NRC. DOT oversees shipper packaging, vehicle placarding, carrier routing, and external contamination limits, while the NRC certifies Type B packaging designs (10 CFR Part 71) and inspects licensee shipping procedures.
Radioactive packages are classified by radioactive contents and activity thresholds, specifically A 1 A_1 A 1 (special form sealed source limit) and A 2 A_2 A 2 (normal form unsealed material limit) tabulated in 49 CFR 173.435:
Excepted Packaging: For limited quantities (e.g., check sources) with surface dose rates ≤ 0.005 mSv/hr \le 0.005\text{ mSv/hr} ≤ 0.005 mSv/hr ( 0.5 mrem/hr 0.5\text{ mrem/hr} 0.5 mrem/hr ).
Type A Packaging: Must withstand normal conditions of transport per 49 CFR 173.465 (water spray, free drop from 1.2 m 1.2\text{ m} 1.2 m , compression, and penetration) without loss of shielding or contents. Used for radiopharmaceutical unit doses up to A 1 A_1 A 1 or A 2 A_2 A 2 (e.g., 99 m Tc ^{99\text{m}}\text{Tc} 99 m Tc , 131 I ^{131}\text{I} 131 I , 18 F ^{18}\text{F} 18 F ).
Type B Packaging: Required for activities exceeding A 1 A_1 A 1 or A 2 A_2 A 2 (e.g., teletherapy 60 Co ^{60}\text{Co} 60 Co or HDR 192 Ir ^{192}\text{Ir} 192 Ir sources). Must survive severe hypothetical accident conditions per 10 CFR Part 71 ( 9 m 9\text{ m} 9 m drop onto unyielding surface, 1 m 1\text{ m} 1 m puncture spike drop, 800 ∘ C 800^\circ\text{C} 80 0 ∘ C fire for 30 minutes, and water submersion).
Labeling and Transport Index (TI)
Packages require two diamond labels on opposite sides. The Transport Index (TI) is the maximum dose rate in mrem/hr \text{mrem/hr} mrem/hr measured at 1 meter 1\text{ meter} 1 meter from the surface (rounded up to one decimal place):
White-I: Surface dose rate ≤ 0.005 mSv/hr \le 0.005\text{ mSv/hr} ≤ 0.005 mSv/hr ( 0.5 mrem/hr 0.5\text{ mrem/hr} 0.5 mrem/hr ); 1 m 1\text{ m} 1 m dose rate background ( TI = 0 \text{TI} = 0 TI = 0 ).
Yellow-II: Surface dose rate > 0.005 mSv/hr > 0.005\text{ mSv/hr} > 0.005 mSv/hr ( 0.5 mrem/hr 0.5\text{ mrem/hr} 0.5 mrem/hr ) up to 0.5 mSv/hr 0.5\text{ mSv/hr} 0.5 mSv/hr ( 50 mrem/hr 50\text{ mrem/hr} 50 mrem/hr ); TI ≤ 1.0 \text{TI} \le 1.0 TI ≤ 1.0 (dose rate at 1 m ≤ 0.01 mSv/hr 1\text{ m} \le 0.01\text{ mSv/hr} 1 m ≤ 0.01 mSv/hr or 1 mrem/hr 1\text{ mrem/hr} 1 mrem/hr ).
Yellow-III: Surface dose rate > 0.5 mSv/hr > 0.5\text{ mSv/hr} > 0.5 mSv/hr ( 50 mrem/hr 50\text{ mrem/hr} 50 mrem/hr ) up to 2.0 mSv/hr 2.0\text{ mSv/hr} 2.0 mSv/hr ( 200 mrem/hr 200\text{ mrem/hr} 200 mrem/hr ); or TI > 1.0 \text{TI} > 1.0 TI > 1.0 up to TI ≤ 10 \text{TI} \le 10 TI ≤ 10 . Packages with TI > 10 \text{TI} > 10 TI > 10 or surface rate > 2.0 mSv/hr > 2.0\text{ mSv/hr} > 2.0 mSv/hr require exclusive-use vehicles. Vehicle placarding is legally mandatory on all four exterior sides for Yellow-III shipments.
Inter-Agency Delineation: OSHA, FDA/CDRH, and the EPA
Medical radiation safety intersects multiple federal agencies:
OSHA (29 CFR 1910.1096): Regulates occupational ionizing radiation protection in workplaces outside NRC or Agreement State purview (e.g., industrial x-ray diffraction, chiropractic clinics, and accelerator facilities in non-Agreement states).
FDA / CDRH (21 CFR Subchapter J): Under the Radiation Control for Health and Safety Act of 1968, the FDA regulates the manufacture and commercial distribution of radiation-emitting electronic devices. Performance standards include 21 CFR 1020.30 (diagnostic x-ray systems), 21 CFR 1020.32 (fluoroscopy entrance air kerma limits: 88 mGy/min 88\text{ mGy/min} 88 mGy/min [ 10 R/min 10\text{ R/min} 10 R/min ] standard mode, 176 mGy/min 176\text{ mGy/min} 176 mGy/min [ 20 R/min 20\text{ R/min} 20 R/min ] high-level control), and the Mammography Quality Standards Act (MQSA; 21 CFR Part 900). Apart from MQSA, which FDA (with certifying states) enforces directly on mammography facilities, FDA's equipment standards bind manufacturers; clinical use of x-ray equipment and operator safety are regulated by the states.
EPA: Sets Clean Air Act radionuclide emission standards in 40 CFR Part 61. Subpart I now applies only to federal facilities that are not NRC licensees; NRC and Agreement State licensees instead meet the 0.1 mSv (10 mrem) per year air-emission constraint in 10 CFR 20.1101(d), often demonstrated with EPA's COMPLY code. The EPA also issues Federal Guidance Reports (FGR 11 internal dose conversion factors, FGR 12 external coefficients, FGR 13 cancer risk coefficients, FGR 14 diagnostic x-ray guidance) and 40 CFR Part 190 environmental standards.
Scientific Advisory & Standard-Setting Organizations
Statutory rules reflect consensus recommendations from non-regulatory advisory bodies:
NCRP: Chartered by US Congress in 1964 (Public Law 88-376). Provides scientific guidance forming the basis of US regulations, including Report 116 (dose limitation), Report 147 (diagnostic x-ray shielding), Report 151 (megavoltage vault shielding), Report 160 (population exposure baseline), and Report 168 (fluoroscopic dose management).
ICRP: International body (Publications 60, 103, 118) defining radiation protection principles: justification, optimization (ALARA), and dose limitation, alongside tissue ( w T w_T w T ) and radiation ( w R w_R w R ) weighting factors.
CRCPD: Conference of Radiation Control Program Directors; drafts the Suggested State Regulations for Control of Radiation (SSRCR), establishing model regulations adopted by state programs.
AAPM & HPS: Professional bodies whose clinical task groups (e.g., AAPM TG-51, TG-108, TG-142) define the accepted standard of medical physics practice.
Regulatory Framework Summary & Clinical Pitfalls
Agency / Organization Statutory Authority Key Regulation / Publication Clinical Jurisdiction Enforceability
US NRC AEA 1954; Energy Reorganization Act 1974 10 CFR Parts 19, 20, 35 Byproduct material; medical radioisotopes Federal law in non-Agreement states & federal sites
Agreement States Section 274b AEA; State Health Codes State Administrative Codes (SSRCR) Byproduct, source, & accelerator radioisotopes State law in 41 Agreement States
US DOT Hazardous Materials Transportation Act 49 CFR Parts 171–178 Package certification, labeling, vehicle placarding Federal law for transit on public roads
US FDA / CDRH FD&C Act Subchapter J; MQSA 21 CFR Parts 900, 1020 Medical x-ray / linac equipment manufacturing Federal law governing device manufacturers
US EPA Clean Air Act; Atomic Energy Act 40 CFR Part 61 (NESHAPs); Federal Guidance Reports 11–14 Air emissions (Subpart I covers non-NRC federal facilities); federal radiation guidance Federal environmental law; guidance reports are advisory
US OSHA OSH Act of 1970 29 CFR 1910.1096 Radiation in non-NRC/non-Agreement workplaces Federal workplace safety law
NCRP / ICRP Congressional Charter (NCRP); NGO (ICRP) NCRP Reports 116, 147, 151; ICRP 103 Advisory shielding models, dose limits, ALARA Advisory unless formally adopted into code
Clinical Practice Pitfalls
Classifying Linear Accelerators as Byproduct Material: Linear accelerators produce radiation electronically and contain no byproduct material (unless activated); their operation, shielding, and surveys are governed by state radiation control agencies or OSHA, not 10 CFR Part 35.
Assuming Cyclotron Radionuclides Are State-Only: Prior to EPAct 2005, accelerator radionuclides were state-regulated NARM. Today, medical cyclotron isotopes ( 18 F ^{18}\text{F} 18 F , 201 Tl ^{201}\text{Tl} 201 Tl ) are legally classified as byproduct material under 10 CFR Part 35.
Misinterpreting Agreement State Authority: Agreement States may enact more stringent safety rules under Category C compatibility, but cannot relax Category A dose limits or Category B transport standards.